Associate Director, Global Finance Commercial FP&A

Alexion•Boston, MA

1d•Hybrid

About The Position

Introduction to role: Are you ready to lead AI-powered forecasting that guides investment choices for therapies serving people with rare diseases? In this role, you will co-lead the medium-to-long range financial outlook for a high-impact therapy area, shaping the Long Term Plan and the narratives that inform senior leaders and the market. You will partner closely with R&D, Global Portfolio Analytics, and Commercial leaders across therapy areas and regions to elevate forecast accuracy, unlock intelligent automation, and build executive-ready insights. Your work will translate complex signals into clear recommendations that help deliver on ambitious targets and, ultimately, accelerate access to life-changing medicines. Do you thrive at the intersection of advanced analytics and executive decision-making? Accountabilities: Therapy Area Forecast Leadership: Co-lead medium-long range financial forecasting for Rare Disease, ensuring robust scenario planning and clear direction for investment and resource allocation. Long Term Planning: Deliver the Long Term Plan by connecting scientific progress and portfolio dynamics to commercial outcomes, partnering with R&D and Global Portfolio Analytics to align assumptions and milestones. Performance Partnership: Partner with Therapeutic Area Commercial Leads to manage financial performance, challenge assumptions, and drive target delivery across markets. Analytics and Automation: Streamline reporting and fortify analytical capabilities to support a rapidly evolving business model, deploying sophisticated solutions and automation that leverage the latest technology and AI models for speed and precision. Advanced Modeling: Prepare complex analytical and driver-based models that deepen business understanding and measurably improve forecast accuracy and cycle time. Executive Readiness: Serve as process owner for Rare Disease Quarterly Business Review, equipping the CEO and senior leaders with crisp, data-backed insights for external earnings communications. Leadership Briefings: Deliver regular, concise financial performance updates to Senior Leadership, Enterprise FP&A, and Group Finance that translate data into action. PowerBI and Anaplan Enablement: Work with Global Finance Services to define essential PowerBI dashboards for decision-making and manage the Anaplan forecasting tool to streamline planning and reporting. Forecast Governance: Drive mid-month and outturn forecast exercises; rigorously assess and challenge key revenue assumptions from therapy areas and regions to maintain credibility and agility. Center of Excellence Oversight: Manage deliverables from the Costa Rica Center of Excellence, ensuring speed, quality, and alignment to business expectations. GMMA Budget Ownership: Own the Global Marketing and Market Access financial budget and monthly cost performance; partner with business leaders to optimize spend and impact. Insightful Commentary: Consolidate monthly commentaries, explain business variances, and systematically identify risks and opportunities versus budget to inform actions. AI Innovation: Discover, evaluate, and implement AI solutions that elevate analytics and insight generation; integrate financial data with external sources to maintain high quality standards and accelerate decisions. When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at pace and challenge perceptions. That's why we work, on average, a minimum of three days per week from the office. But that doesn't mean we're not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world. Why AstraZeneca: Here, your financial leadership fuels medicines that change lives. You will work with diverse experts who bring science, analytics, and commercial insight together to solve real patient challenges, using modern tools like AI-enabled forecasting and dynamic dashboards to move with speed and clarity. We value kindness alongside ambition, and we create momentum by bringing unexpected teams together to spark bold ideas—giving you the platform and support to turn rigorous analysis into decisions that shape the future of rare disease therapies worldwide. Call to Action: If you are ready to turn complex signals into confident guidance and lead AI-driven forecasting that accelerates access to life-changing medicines, step forward and make your impact now!

Requirements

Co-Lead together with the Director of Global Commercial FP&A, the Global Rare Disease Therapy Area medium-long range financial forecasting.
Deliver Long Term Plan (LTP) while leveraging key partnerships within R&D and Global Portfolio Analytics.
Partner with Therapeutic Area Commercial Leads to manage financial performance and target delivery.
Streamline and improve reporting and analytical ability to support rapidly changing business structure and environment, utilizing sophisticated solutions and automation utilizing latest technology and AI models
Prepare complex analytical models to support deeper business understanding and improved forecast accuracy.
Process owner for Rare Disease Quarterly Business Review (QBR) to prepare CEO for external earnings release.
Deliver regular financial performance briefings to Senior Leadership team, Enterprise Financial Planning and Analytics and AZ Group Finance.
Work closely with GFS to determine the essential analytical dashboards in PowerBI required to support business decision and manage Anaplan forecasting tool to streamline forecasting and reporting.
Drive the mid-month and Outturn forecast exercise, understanding and challenging the key assumptions used to determine the latest revenue forecast provided by the TAs and Regions.
Manage the key deliverables from our Center of Excellence in Costa Rica (GFS-Global Finance Services) aligned with business expectations.
Responsible for the GMMA (Global Marketing and Market Access) financial budget and monthly cost performance, working closely with the GMMA Business Leaders.
Work closely with the Global Commercial Finance TA Leaders to consolidate monthly commentaries and explanations of business variances and identify periodically risk & opportunities vs budget.
Discover, investigate, and implement AI solutions that directly influence business analytics and insights, enabling faster and more informed decision-making.
Ensure the effective use of financial data and integrate it with external sources to maintain high quality standards.

Nice To Haves

Track record leading global commercial FP&A forecasting cycles, including LTP, mid-month, and outturn processes.
Advanced proficiency with Anaplan model building and PowerBI (including DAX) to create executive-ready dashboards.
Experience applying AI/ML techniques in finance to automate data pipelines, enhance forecasting, and accelerate insights.
Proven success partnering with R&D, Portfolio Analytics, and Commercial leaders across multiple regions and therapy areas.
Executive-grade communication skills with experience preparing CEO-level materials and external earnings support.
Background in biopharma or healthcare markets; rare disease exposure a plus.
Experience overseeing Center of Excellence or shared services teams; Spanish language skills beneficial.
Professional qualifications such as MBA, CPA, or CFA valued.

Responsibilities

Co-Lead together with the Director of Global Commercial FP&A, the Global Rare Disease Therapy Area medium-long range financial forecasting.
Deliver Long Term Plan (LTP) while leveraging key partnerships within R&D and Global Portfolio Analytics.
Partner with Therapeutic Area Commercial Leads to manage financial performance and target delivery.
Streamline and improve reporting and analytical ability to support rapidly changing business structure and environment, utilizing sophisticated solutions and automation utilizing latest technology and AI models
Prepare complex analytical models to support deeper business understanding and improved forecast accuracy.
Process owner for Rare Disease Quarterly Business Review (QBR) to prepare CEO for external earnings release.
Deliver regular financial performance briefings to Senior Leadership team, Enterprise Financial Planning and Analytics and AZ Group Finance.
Work closely with GFS to determine the essential analytical dashboards in PowerBI required to support business decision and manage Anaplan forecasting tool to streamline forecasting and reporting.
Drive the mid-month and Outturn forecast exercise, understanding and challenging the key assumptions used to determine the latest revenue forecast provided by the TAs and Regions.
Manage the key deliverables from our Center of Excellence in Costa Rica (GFS-Global Finance Services) aligned with business expectations.
Responsible for the GMMA (Global Marketing and Market Access) financial budget and monthly cost performance, working closely with the GMMA Business Leaders.
Work closely with the Global Commercial Finance TA Leaders to consolidate monthly commentaries and explanations of business variances and identify periodically risk & opportunities vs budget.
Discover, investigate, and implement AI solutions that directly influence business analytics and insights, enabling faster and more informed decision-making.
Ensure the effective use of financial data and integrate it with external sources to maintain high quality standards.

Benefits

Benefits offered included a qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans.

Stand Out From the Crowd

Upload your resume and get instant feedback on how well it matches this job.

Upload and Match Resume